Dov Bloch, MD
Otolaryngology · Danbury, CTNPI 1053316414
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Intersect ENT, Inc. at 38.2% of the total. Among otolaryngology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $97.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Aerin Medical Inc.$3K
- Inspire Medical Systems, Inc.$834
- GSK$251
- Regeneron Healthcare Solutions, Inc.$143
- Checkpoint Surgical, Inc$103
- plus $466 from 11 others
What the payments were for
- Travel & lodging$3,91656%
- Food & beverage$3,09744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 17 | $2,681 |
| Aerin Medical Inc. | 15 | $2,537 |
| Inspire Medical Systems, Inc. | 2 | $834 |
| GSK | 15 | $251 |
| Regeneron Healthcare Solutions, Inc. | 2 | $143 |
| Checkpoint Surgical, Inc | 2 | $103 |
| Integra Lifesciences Corporation | 1 | $75 |
| Optinose US, Inc. | 3 | $68 |
| Stryker | 2 | $61 |
| Medtronic | 3 | $59 |
| Endo USA, Inc. | 3 | $58 |
| Johnson & Johnson | 2 | $44 |
| Merck | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Amgen | 1 | $22 |
| Smith+Nephew | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$2,337
- SINUVA$2,240
- Inspire Upper Airway Stimulation System$834
- RHINAER STYLUS$513
- PROPEL$125
- LIBTAYO$125
How this compares
$7,013 in reported general payments places this provider in the 90th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine-FluticasoneAzelastine/Fluticasone | 56 | $6,037 |
| Fluticasone Propionate | 375 | $5,133 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $3,046 |
| Famotidine | 343 | $3,038 |
| Ipratropium Bromide | 75 | $1,797 |
| Ofloxacin | 38 | $1,690 |
| Mometasone Furoate | 36 | $1,648 |
| Azelastine Hcl | 73 | $1,138 |
| Fluocinolone Acetonide Oil | 16 | $651 |
| Pantoprazole Sodium | 58 | $581 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 72 | $554 |
| Methylprednisolone | 62 | $354 |
| Mupirocin | 36 | $285 |
| CefuroximeCefuroxime Axetil | 17 | $256 |
| Nystatin | 12 | $190 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Danbury
- Jay KlarsfeldDanbury$4K
- Michael DrobbinDanbury$3K
- Danielle WarnerDanbury$3K
- Mark DelacureDanbury$2K
- Michael BardDanbury$2K
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard StupakWestport$48K
- Belachew TessemaFarmington$45K
- Seth BrownFarmington$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.